200 Participants Needed

Auditory Stimulation for Schizophrenia

(RESPITE Trial)

CA
Overseen ByChloe A Huston, MA
Age: 18 - 65
Sex: Any
Trial Phase: Academic
Sponsor: Fabio Ferrarelli
Must be taking: Antipsychotics
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores differences in sleep between individuals with certain mental health conditions, such as schizophrenia, and those without. It tests whether playing sounds during deep sleep can enhance brain activity and thinking skills. Participants will receive either real sound stimulation (closed-loop auditory stimulation) or fake sound stimulation (sham auditory stimulation) on different nights. Individuals with schizophrenia or similar conditions who have lived with these conditions for five years or less, as well as healthy individuals without a psychiatric history, may be eligible to join. As an unphased trial, this study provides a unique opportunity to contribute to groundbreaking research on sleep and mental health.

Will I have to stop taking my current medications?

The trial information does not specify whether participants need to stop taking their current medications. However, it mentions that participants with early-course schizophrenia can have a lifetime exposure to antipsychotic medications of up to 5 years, suggesting that continuing current antipsychotic medications might be allowed.

What prior data suggests that auditory stimulation is safe for individuals with schizophrenia?

Research has shown that closed-loop auditory stimulation is generally safe for people with schizophrenia. Studies have found that this method can enhance certain brain activities during sleep without causing major side effects. Participants have tolerated the treatment well, with no reports of serious negative effects. This suggests the treatment is safe for individuals, including those with mental health conditions like schizophrenia.12345

Why are researchers excited about this trial?

Researchers are excited about auditory stimulation for schizophrenia because it offers a non-invasive approach that could enhance cognitive function and reduce symptoms without the side effects associated with medications like antipsychotics. Unlike typical treatments that primarily target neurotransmitter imbalances, closed-loop auditory stimulation works by synchronizing brain waves, potentially leading to improved brain connectivity and function. This innovative method could provide quicker relief and is particularly appealing for patients looking for alternatives to drug-based therapies.

What evidence suggests that auditory stimulation is effective for schizophrenia?

Research has shown that closed-loop auditory stimulation, which plays sounds during specific sleep stages, might improve sleep quality and brain function in people with schizophrenia. Studies have found that this technique can enhance memory by boosting sleep spindles, brain waves crucial for memory and learning. Early results indicated that patients with schizophrenia who received this treatment had better memory compared to those who did not. In this trial, participants will experience different sequences of sham and active auditory stimulation to evaluate its effects. This method is gaining popularity because it addresses sleep issues common in schizophrenia, potentially leading to better mental health.25678

Who Is on the Research Team?

Fabio Ferrarelli, MD, PhD | University ...

Fabio Ferrarelli, MD, PhD

Principal Investigator

University of Pittsbrugh

Are You a Good Fit for This Trial?

This trial is for individuals aged 18-40 with early-course schizophrenia, schizophreniform, or schizoaffective disorder without a family history of similar conditions. They must have experienced psychosis for ≤5 years and had limited exposure to antipsychotic meds (≤5 years). Healthy controls without psychiatric disorders can also join. Exclusions include pregnancy, inability to consent, intellectual disabilities, significant neurological issues, certain sleep disorders, substance abuse (except cannabis/alcohol), and medical illnesses affecting the brain.

Inclusion Criteria

I have been diagnosed with schizophrenia or a related disorder, without drug causes, and haven't had a psychotic episode before.
My immediate family has no history of schizophrenia or mood disorders with psychosis.
My condition is early-stage schizophrenia.
See 4 more

Exclusion Criteria

Current or past co-morbidity for alcohol or psychoactive substance dependence
Substance abuse other than cannabis and/or alcohol within the past one year
DSM-IV intellectual disability
See 12 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Baseline Assessment

Participants complete clinical evaluation, IQ assessment, and initial sleep EEG recordings

1 week
1 visit (in-person)

Treatment

Participants undergo closed-loop auditory stimulation during sleep across multiple nights

4 weeks
4 visits (in-person)

Follow-up

Participants are monitored for changes in sleep spindle and slow wave activity and memory consolidation

2 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Closed-loop auditory stimulation
  • Sham auditory stimulation
Trial Overview The study aims to compare brain activity during sleep between healthy individuals and those with schizophrenia-related diagnoses. It will test if playing tones during deep sleep can improve specific sleep features and cognitive performance in patients. Participants will receive either sham auditory stimulation or closed-loop auditory stimulation as part of the research.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Group I: Experimental: Night three- sham, night four - activeExperimental Treatment2 Interventions
Group II: Experimental: Night three - active, night four - shamExperimental Treatment2 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

Fabio Ferrarelli

Lead Sponsor

Trials
2
Recruited
280+

National Institute of Mental Health (NIMH)

Collaborator

Trials
3,007
Recruited
2,852,000+

Published Research Related to This Trial

A randomized-controlled trial involving 144 patients with schizophrenia will test the efficacy of high-frequency transcranial random noise stimulation (hf-tRNS) to alleviate persistent symptoms, with the primary outcome being a 25% reduction in symptoms after 10 sessions.
The study aims to explore not only the clinical effects of hf-tRNS on symptoms like auditory hallucinations but also its impact on brain activity and cognitive functions, potentially establishing it as a new treatment option for patients resistant to traditional antipsychotics.
Examining transcranial random noise stimulation as an add-on treatment for persistent symptoms in schizophrenia (STIM'Zo): a study protocol for a multicentre, double-blind, randomized sham-controlled clinical trial.Brunelin, J., Mondino, M., Haesebaert, J., et al.[2022]
The proposed closed-loop auditory stimulation system, which uses machine learning for real-time sleep stage tracking, effectively regulates sleep by driving EEG slow oscillations in ten subjects, showing immediate modulation effects after stimulation.
This new system demonstrated greater reliability and flexibility compared to existing methods, achieving consistent results across almost all participants in the experiment.
A system based on machine learning for improving sleep.Lu, J., Yan, M., Wang, Q., et al.[2023]
In patients with schizophrenia and major depression, higher stimulation frequencies enhanced the amplitude of the N1 auditory evoked potential, indicating altered auditory processing in these conditions.
Schizophrenic patients showed a prolonged latency of the N1 component and P2 latency was also extended in those treated with high-potency neuroleptic drugs, suggesting that medication may affect auditory processing timing.
Influence of stimulation parameters on auditory stimulus processing in schizophrenia and major depression: an auditory evoked potential study.Adler, G., Adler, J., Schneck, M., et al.[2019]

Citations

The Effects of Auditory Stimulation During Sleep on Brain ...Adult participants screened to exclude a personal history of mental illness, family history of schizophrenia spectrum disorder, and psychoactive medication use.
Neurophysiological effects of targeting sleep spindles with ...Our results validate the use of closed-loop auditory stimulation ... schizophrenia [6–8]). However, the majority of evidence concerning ...
0113 Evaluating Closed-Loop Auditory Stimulation During ...If it does, we will test the effects of stimulation on sleep-dependent memory deficits in patients with schizophrenia. Closed-loop auditory stimulation ...
Closed-Loop Auditory Stimulation (CLAS) During Sleep ...Exclusion criteria included current intoxication or illness at intake or during the study, self-reported chronic brain or mental illness including epilepsy ...
Auditory stimulation in‐phase with slow oscillations to ...The mean (SEM, range) age was 40.7 (2.2, 23–53) years. In all, 11 patients had paranoid schizophrenia and seven had a schizoaffective psychosis.
The effects of closed-loop auditory stimulation on sleep ...In schizophrenia, CLASS increased SO activity and spindle activity that was phase-locked to the SO upstate but failed to improve declarative memory [18]. Both ...
0113 Evaluating Closed-Loop Auditory Stimulation During ...... stimulation on sleep-dependent memory deficits in patients with schizophrenia. Closed-loop auditory stimulation shows promise as a safe ...
Closed‐loop auditory stimulation of slow‐wave sleep in ...Reduced sleep spindle activity in schizophrenia patients. The American Journal of Psychiatry, 164(3), 483–492. 10.1176/ajp.2007.164.3.483 [DOI] [PubMed] ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security